NGS 라이브러리 조제 시장 : 컴포넌트 유형, 시퀀스 유형, 워크플로우 단계, 애플리케이션, 최종사용자별 - 세계 예측(2025-2030년)

The NGS Library Preparation Market was valued at USD 2.29 billion in 2024 and is projected to grow to USD 2.48 billion in 2025, with a CAGR of 8.84%, reaching USD 3.81 billion by 2030.

NGS library preparation represents a critical phase in the next-generation sequencing process, setting the stage for accurate genomic analyses and insights. This introduction explores the evolution and importance of library preparation, highlighting its role as the foundation for reliable sequencing outcomes. In recent years, rapid advancements in technology and bioinformatics have heightened the demand for robust and efficient library preparation. Researchers and industry experts have increasingly recognized the necessity of optimizing each preparatory step to enhance overall data quality and throughput. The drive for higher accuracy, lower error rates, and expanded capabilities across various applications has spurred innovative solutions. Furthermore, market dynamics are shaped by evolving regulatory landscapes and rising applications in precision medicine, drug discovery, and diagnostic innovations. With a strategic focus on integrating cutting-edge instrumentation, reagents, and software support, the evolving environment of NGS library preparation continues to open up new avenues for research and commercial opportunities. The ongoing efforts to streamline workflows demonstrate the field's adaptability, assuring stakeholders a future marked by efficiency and significant scientific breakthroughs.

This comprehensive report sets out to provide a detailed investigation of current trends, transformative shifts in market dynamics, and deep segmentation insights that influence strategic decision making. The following sections deliver a systematic exploration of the factors shaping the market and propose actionable recommendations for industry leaders aiming to capitalize on these emerging trends.

Transformative Shifts in the NGS Landscape

Over recent years, the NGS landscape has experienced transformative shifts, marked by remarkable technological advances and evolving market structures. Stakeholders have witnessed the move from traditional, time-consuming methodologies to innovative, automated, and integrated workflows that significantly accelerate throughput and enhance analytical precision. The integration of advanced robotics, artificial intelligence, and sophisticated software algorithms has revolutionized sample processing, contributing to a new biological discovery paradigm. Unprecedented investments in research and development have spurred improvements across automated workstations, specialized library preparation systems, and high-throughput sequencers, reinforcing the market's commitment to efficiency and innovation.

Moreover, novel reagents and consumables now offer improved stability and sensitivity, which, when coupled with next-generation analysis software and comprehensive support services, are reshaping cost structures and operational strategies. The resulting synergy not only optimizes laboratory workflows but also enables deeper, more actionable insights from complex genomic data. The driving forces behind these changes include enhanced computational capabilities, growing demand in diagnostics and therapeutic research, and the continual push for personalized medicine. Consequently, the NGS market is witnessing a paradigm shift with research institutions and commercial enterprises aligning their strategic investments with these technological advancements, setting a new benchmark for precision and scalability in genomic research.

Key Segmentation Insights Driving Market Analysis

In-depth segmentation analysis reveals numerous variables that are instrumental in garnering a comprehensive understanding of the NGS library preparation market. When examining the market by component type, the focus spans across critical areas including instruments, reagents and consumables, and software and services. Instruments are commonly evaluated in terms of their subsegments such as automated workstations, library preparation systems, and sequencers, which collectively form the backbone of current laboratory automation. Equally significant, the reagents and consumables segment is broken down into specialized areas such as beads, buffers, enzymes, and kits, all contributing to the effectiveness and reliability of library preparation protocols. The services segment extends to analysis software, consumables support, and setup assistance, further enhancing overall system performance.

Turning to sequencing type segmentation, classifications include targeted genome sequencing, whole exome sequencing, and whole genome sequencing. Each sequencing type offers specific advantages and challenges, influencing the choice of library preparation techniques and analytical frameworks. The market is also analyzed by workflow stage, which covers library amplification, library construction, quality control, and sample preparation. These stages highlight step-by-step improvements and pinpoint areas for process optimization. Additionally, application based segmentation targets fields such as disease diagnosis, drug and biomarker research, and precision medicine; these applications drive innovation in detection and treatment methodologies. Finally, segmentation by end user emphasizes the particular needs and investments of academic and research institutes, contract research organizations, and pharmaceutical and biotechnology companies. This layered analysis of segmentation variables provides stakeholders a detailed roadmap for navigating the complexities of the modern NGS landscape.

Based on Component Type, market is studied across Instruments, Reagents & Consumables, and Software & Services. The Instruments is further studied across Automated Workstations, Library Preparation Systems, and Sequencers. The Reagents & Consumables is further studied across Beads, Buffers, Enzymes, and Kits. The Software & Services is further studied across Analysis Software, Consumables Support, and Setup Assistance.

Based on Sequencing Type, market is studied across Targeted Genome Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.

Based on Workflow Stage, market is studied across Library Amplification, Library Construction, Quality Control, and Sample Preparation.

Based on Application, market is studied across Disease Diagnosis, Drug & Biomarker Research, and Precision Medicine.

Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.

Key Regional Insights Across Global Markets

A detailed regional analysis of the NGS library preparation market shows varying dynamics across major global areas. In the Americas, a well-established research infrastructure and a high concentration of biotechnology firms fuel the rapid adoption of cutting-edge sequencing technologies. Economic strengths and strategic investments in scientific research underpin robust market growth and the rapid integration of pioneering practices within this region.

In the Europe, Middle East & Africa region, diverse regulatory environments and a high level of academic innovation contribute significantly to market evolution. Strategic alliances, collaborations, and targeted governmental initiatives are fostering growth and broadening the accessibility of advanced genomic solutions across these territories. Research institutions and commercial enterprises are constantly refining their approaches, ensuring that traditional practices blend seamlessly with modern technological advancements.

Meanwhile, the Asia-Pacific region has emerged as a dynamic hub with rapid industrialization and burgeoning research activities. The swift rise of private and state-backed funding reinforces market development while spurring local innovations that push the boundaries of library preparation technology. Altogether, the interplay of these regions is driving a competitive yet collaborative market landscape, where knowledge sharing and technological convergence pave the way for groundbreaking scientific discoveries.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Driving Innovation in NGS Library Preparation

Notable industry players form the core of innovation and market evolution in the NGS library preparation space. Leading companies such as 10x Genomics, Inc. and Agilent Technologies, Inc. are at the forefront of engineering sophisticated instruments and innovative reagents that cater to the high demands of sequencing accuracy and throughput. The contributions of Beckman Coulter, Inc. and Becton, Dickinson and Company have furthered the development of streamlined workflow solutions and robust quality control systems, ensuring impeccable performance under varied research conditions.

Other influential entities including BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., and Danaher Corporation, along with digital innovators such as DNAnexus, Inc. and Dnastar, Inc., continue to redefine best practices in the laboratory. Eurofins Scientific SE and F. Hoffmann-La Roche Ltd. stand out for their expansive approach to diagnostics and therapeutic research. Likewise, powerhouses such as Illumina, Inc. and Integrated DNA Technologies, Inc. drive continuous improvements in high-throughput sequencing capabilities. Additional contributions from Macrogen, Inc., Merck KGaA, and Meridian Bioscience, Inc. have solidified the market position while New England Biolabs, Inc., NimaGen B.V., and Pacific Biosciences of California, Inc. lead with breakthrough innovations in sequencing technology. Lastly, strong market influence is also observed from PerkinElmer, Inc., Promega Corporation, Qiagen GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation, whose collective strategies are instrumental in fostering industry-wide advancements.

The report delves into recent significant developments in the NGS Library Preparation Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, DNAnexus, Inc., Dnastar, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina, Inc., Integrated DNA Technologies, Inc., Macrogen, Inc., Merck KGaA, Meridian Bioscience, Inc., New England Biolabs, Inc., NimaGen B.V., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation. Actionable Recommendations for Market Leaders

Market leaders are encouraged to foster innovation by embracing transformative technologies and aligning strategic investments with the evolving landscape of NGS library preparation. It is vital to leverage advancements in automation and bioinformatics to streamline workflows, thereby reducing turnaround times while maintaining the highest quality standards. Leaders should focus on integrating modular systems that enable scalability and adaptability, responding to the diverse needs of research applications. Investing in collaborative research and technological cross-pollination between instruments, reagents, and software can yield competitive advantages and unlock new revenue streams.

Engaging in cross-sector partnerships is another key strategy, particularly by interfacing with academic institutions and contract research organizations to promote real-world testing and iterative enhancements. Emphasis should be placed on robust quality control protocols and continuous training programs for technical personnel to stay ahead of technological disruptions. Furthermore, strategic geographic expansion and localized partnerships can widen market reach, especially in emerging regions rich with untapped research potential. Establishing a forward-thinking roadmap that anticipates market trends and allocates resources toward both incremental improvements and disruptive innovation is essential for sustained success in the competitive landscape of NGS library preparation.

Conclusion and Future Outlook

In conclusion, the evolving landscape of NGS library preparation is witnessing significant innovations that are reshaping research methodologies and market dynamics. The convergence of transformative technologies with detailed segmentation insights and diverse regional influences outlines a promising future for genomic research. As advancements in automation, reagent efficacy, and software support continue to accelerate, the industry is poised to deliver unparalleled accuracy and efficiency in sequencing workflows.

The nuanced understanding of the market-spanning component types, sequencing methods, operational workflows, applications, and end user requirements-underscores the need for adaptable and forward-looking strategies. Market players who embrace innovation, foster collaborative partnerships, and invest in continuous improvement will be better equipped to capture emerging opportunities. With a clear focus on quality and technological synergy, the future of NGS library preparation looks robust, offering an exciting horizon for both scientific exploration and commercial growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases worldwide
    • 5.1.1.2. Increase in government funding for genomics research
    • 5.1.1.3. Growing focus on biomarker discovery and validation
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity of protocols and biases issues
  • 5.1.3. Opportunities
    • 5.1.3.1. Adopting AI and machine learning technologies to optimize workflows
    • 5.1.3.2. Development of novel library preparation technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Ensuring data accuracy and integrity from NGS
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component Type: Increasing adoption of instruments for their precision and efficiency
  • 5.2.2. End User: Expanding utilization of NGS library preparation in contract research organizations
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. NGS Library Preparation Market, by Component Type

• 6.1. Introduction
• 6.2. Instruments
  • 6.2.1. Automated Workstations
  • 6.2.2. Library Preparation Systems
  • 6.2.3. Sequencers
• 6.3. Reagents & Consumables
  • 6.3.1. Beads
  • 6.3.2. Buffers
  • 6.3.3. Enzymes
  • 6.3.4. Kits
• 6.4. Software & Services
  • 6.4.1. Analysis Software
  • 6.4.2. Consumables Support
  • 6.4.3. Setup Assistance

7. NGS Library Preparation Market, by Sequencing Type

• 7.1. Introduction
• 7.2. Targeted Genome Sequencing
• 7.3. Whole Exome Sequencing
• 7.4. Whole Genome Sequencing

8. NGS Library Preparation Market, by Workflow Stage

• 8.1. Introduction
• 8.2. Library Amplification
• 8.3. Library Construction
• 8.4. Quality Control
• 8.5. Sample Preparation

9. NGS Library Preparation Market, by Application

• 9.1. Introduction
• 9.2. Disease Diagnosis
• 9.3. Drug & Biomarker Research
• 9.4. Precision Medicine

10. NGS Library Preparation Market, by End User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas NGS Library Preparation Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific NGS Library Preparation Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa NGS Library Preparation Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Twist Bioscience enhances NGS library preparation with cost-effective high throughput FlexPrep kit
  • 14.3.2. Qiagen innovation propels precision medicine with multiomic NGS library preparation kit
  • 14.3.3. SPT Labtech and Watchmaker Genomics team up to enhance NGS library preparation with automated sequencing solutions
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Beckman Coulter, Inc.
• 4. Becton, Dickinson and Company
• 5. BGI Genomics Co., Ltd.
• 6. Bio-Rad Laboratories, Inc.
• 7. Danaher Corporation
• 8. DNAnexus, Inc.
• 9. Dnastar, Inc.
• 10. Eurofins Scientific SE
• 11. F. Hoffmann-La Roche Ltd.
• 12. Illumina, Inc.
• 13. Integrated DNA Technologies, Inc.
• 14. Macrogen, Inc.
• 15. Merck KGaA
• 16. Meridian Bioscience, Inc.
• 17. New England Biolabs, Inc.
• 18. NimaGen B.V.
• 19. Pacific Biosciences of California, Inc.
• 20. PerkinElmer, Inc.
• 21. Promega Corporation
• 22. Qiagen GmbH
• 23. Tecan Trading AG
• 24. Thermo Fisher Scientific Inc.
• 25. Twist Bioscience Corporation